ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
2,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
3,2,Headache,Headaches NEC,Headaches,Nerv,N
4,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
5,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
5,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
5,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
6,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
8,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8,2,False positive investigation result,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
9,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9,3,False positive investigation result,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
9,4,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
10,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
10,2,Acute pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
10,3,Myocardial stunning,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
10,4,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
11,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
12,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
13,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
14,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
